EUVIMEDEUVIMED entdecken
Open Access

Cost-efficient and Accurate Risk Assessment Instruments in Type 2 Diabetics with Greatest Risk for Cardiovascular Disease

Meghana Kaipa, Devendra K Agrawal

Cardiology and Cardiovascular Medicine · 2026 · 10 (2)

DOI: 10.26502/fccm.92920485 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology and Cardiovascular Medicine, 2026. Verfasst von Meghana Kaipa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Research, Western University of Health Sciences, Pomona, California, USA. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ASCVD Risk CalculatorCardiovascular Disease RiskClinical Decision-MakingFramingham Risk ScorePreventative MedicineQRISK ModelRisk Prediction ModelsScreening ToolsType 2 Diabetes MellitusUKPDS Risk Engine

Autor:innen und Institutionen

  • Department of Translational Research, Western University of Health Sciences, Pomona, California, USA.

Förderung

  • NIAID NIH HHS

Zitieren

APA

Kaipa, M., & Agrawal, D. K. (2026). Cost-efficient and Accurate Risk Assessment Instruments in Type 2 Diabetics with Greatest Risk for Cardiovascular Disease. Cardiology and Cardiovascular Medicine, 10(2). https://doi.org/10.26502/fccm.92920485

Vancouver

Kaipa M, Agrawal DK. Cost-efficient and Accurate Risk Assessment Instruments in Type 2 Diabetics with Greatest Risk for Cardiovascular Disease. Cardiology and Cardiovascular Medicine. 2026;10(2). doi:10.26502/fccm.92920485

BibTeX
@article{Kaipa2026,
  author = {Kaipa, Meghana and Agrawal, Devendra K},
  title = {Cost-efficient and Accurate Risk Assessment Instruments in Type 2 Diabetics with Greatest Risk for Cardiovascular Disease},
  journal = {Cardiology and Cardiovascular Medicine},
  year = {2026},
  volume = {10},
  number = {2},
  doi = {10.26502/fccm.92920485}
}
Kostenlos starten →